These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8427573)

  • 41. Resident Rounds: Part III--Case Report: Metastatic Multiple Myeloma.
    Scott JF; Merati M; Honda K; Cooper KD; Reichert B
    J Drugs Dermatol; 2015 Dec; 14(12):1485-6. PubMed ID: 26741539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
    Hughes M; Micallef-Eynaud P
    Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple myeloma preceding the development of chronic myelogenous leukemia.
    Nitta M; Tsuboi K; Yamashita S; Kato M; Hayami Y; Harada S; Komatsu H; Iida S; Banno S; Wakita A; Ueda R
    Int J Hematol; 1999 Apr; 69(3):170-3. PubMed ID: 10222655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new sarcomatoid variant of multiple myeloma in a 20-year-old male.
    Gauer IC; Hagen V; Merz H
    Ann Hematol; 2004 Apr; 83(4):251-2. PubMed ID: 14513288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
    Terpos E; Rezvani K; Basu S; Milne AE; Rose PE; Scott GL; Rahemtulla A; Samson D; Apperley JF
    Eur J Haematol; 2005 Nov; 75(5):376-83. PubMed ID: 16191086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia].
    Kozuka T; Fukuda S; Imai T; Sezaki T
    Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple myeloma presenting as primary non-secretory plasma cell leukemia.
    Khunger JM; Sharma M; Talib VH
    Indian J Pathol Microbiol; 2003 Jan; 46(1):104-5. PubMed ID: 15027746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review: extramedullary disease in multiple myeloma.
    Madan S; Kumar S
    Clin Adv Hematol Oncol; 2009 Dec; 7(12):802-4. PubMed ID: 20332751
    [No Abstract]   [Full Text] [Related]  

  • 50. [Multiple extra-bone sites of Kahler's disease].
    Hauteville D; Mayan B; Verdier M; Levot J; Bussière H; Jaubert D
    Ann Med Interne (Paris); 1986; 137(7):548-51. PubMed ID: 3813295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous extramedullary plasmacytomas.
    Wuepper KD; MacKenzie MR
    Arch Dermatol; 1969 Aug; 100(2):155-64. PubMed ID: 4183809
    [No Abstract]   [Full Text] [Related]  

  • 52. Plasma cell leukemia--a case report.
    Ng SC; Lee MK
    Singapore Med J; 1989 Aug; 30(4):408-9. PubMed ID: 2814549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cutaneous localization of multiple myeloma on the tract of a central venous catheter].
    Kerob D; Vantelon JM; Ribrag V; Bosq J; Desruennes E; Bourhis JH; Avril MF
    Ann Dermatol Venereol; 2002 Mar; 129(3):311-4. PubMed ID: 11988688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature.
    Alexandrescu DT; Koulova L; Wiernik PH
    Clin Exp Dermatol; 2005 Jul; 30(4):391-4. PubMed ID: 15953079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple myeloma with cutaneous dissemination.
    Ramachandran KA; Duggal RK
    J Assoc Physicians India; 2000 Jun; 48(6):652-3. PubMed ID: 11273553
    [No Abstract]   [Full Text] [Related]  

  • 56. Primary lymph node plasmacytomas (plasmacytic lymphomas).
    Menke DM; Horny HP; Griesser H; Tiemann M; Katzmann JA; Kaiserling E; Parwaresch R; Kyle RA
    Am J Clin Pathol; 2001 Jan; 115(1):119-26. PubMed ID: 11190797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical gastrointestinal plasmacytomas presenting with gastrointestinal bleeding in a patient with multiple myeloma.
    Güngör G; Göktepe MH; Kayaçetın E; Tuna T; Esen H; Demır A
    Turk J Gastroenterol; 2012 Feb; 23(1):85-7. PubMed ID: 22505389
    [No Abstract]   [Full Text] [Related]  

  • 58. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggressive multiple myeloma presenting as mesenteric panniculitis.
    Goh J; Otridge B; Brady H; Breatnach E; Dervan P; MacMathuna P
    Am J Gastroenterol; 2001 Jan; 96(1):238-41. PubMed ID: 11197260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of recurrent Sweet's syndrome in an 80-year-old man: a clue to an underlying malignancy.
    Choi HJ; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    Int J Dermatol; 2006 Apr; 45(4):457-9. PubMed ID: 16650178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.